Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
14m agoTimberland Bancorp Reports Second Fiscal Quarter Net Income of $7.1 Million
41m agoCPKC increases dividend by 17.5 percent
41m agoWaldencast announces conclusion of SEC investigation
41m agoNektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets
42m agoF5 to Host Analyst and Investor Meeting on May 28, 2026
Cue Biopharma logo

Cue Biopharma

About

Cue Biopharma (NASDAQ:CUE) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 22 2026
Cue Biopharma Announces 1-for-30 Reverse Stock Split
Apr 15 2026
Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026
Apr 8 2026
Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement
Mar 27 2026
Cue Biopharma Announces CEO Transition
Mar 26 2026
Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026

Financials

Revenue
$27.47 M
Market Cap
$17.57 M
EPS
-0.28

Community Chat

Ask AI

6ix6ixAIEvents